A detailed history of Jacobs Levy Equity Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 3,693,663 shares of EW stock, worth $260 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
3,693,663
Previous 1,086,713 239.89%
Holding current value
$260 Million
Previous $100 Million 142.82%
% of portfolio
0.99%
Previous 0.43%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $156 Million - $244 Million
2,606,950 Added 239.89%
3,693,663 $244 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $27.8 Million - $31.1 Million
-329,554 Reduced 23.27%
1,086,713 $100 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $70.9 Million - $93.4 Million
-977,496 Reduced 40.84%
1,416,267 $135 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $9.19 Million - $11.6 Million
148,989 Added 6.64%
2,393,763 $183 Million
Q3 2023

Nov 16, 2023

BUY
$69.28 - $93.38 $40.3 Million - $54.3 Million
582,028 Added 35.0%
2,244,774 $156 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $112 Million - $130 Million
1,375,361 Added 478.58%
1,662,746 $157 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $6.17 Million - $7.02 Million
83,031 Added 40.63%
287,385 $23.8 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $14 Million - $17.9 Million
204,354 New
204,354 $15.2 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $262,586 - $328,108
-3,132 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $375,460 - $432,677
-4,772 Reduced 60.37%
3,132 $262,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $5.03 Million - $6.41 Million
-70,229 Reduced 89.88%
7,904 $721,000
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $3.55 Million - $4.62 Million
52,806 Added 208.5%
78,133 $6.24 Million
Q2 2020

Aug 17, 2020

BUY
$57.54 - $76.95 $1.39 Million - $1.86 Million
24,107 Added 1975.98%
25,327 $1.75 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $1.66 Million - $1.9 Million
-23,090 Reduced 94.98%
1,220 $285,000
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $1.5 Million - $1.83 Million
24,310 New
24,310 $5.35 Million
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $73,014 - $88,236
-1,720 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $3.2 Million - $4.08 Million
-85,912 Reduced 98.04%
1,720 $240,000
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $3.46 Million - $4.03 Million
-102,387 Reduced 53.88%
87,632 $9.88 Million
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $361,775 - $387,096
-9,969 Reduced 4.98%
190,019 $20.8 Million
Q2 2017

Nov 09, 2017

BUY
N/A
199,988
199,988 $23.6 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.